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Immunohistological Characterization of 
Intraepithelial and Lamina Propria 
Lymphocytes in Control Ileum and Colon 
and in Inflammatory Bowel Disease 
ICHIRO HIRATA, MD, GABRIEL BERREBI, MD, LINDA L. AUSTIN, BA, 
DAVID F. KEREN, MD, and WILLIAM O. DOBBINS III, MD 
Using monoclonal antibodies to T and B lymphocytes, to natural killer cells, and to 
HLA-DR antigen, we characterized the lymphocyte population within the epithelial and 
lamina propria regions in control intestine and colon, and in grossly involved and in 
grossly uninvolved intestine and colon of patients with active inflammatory bowel disease. 
There were significantly more intraepithelial T cells in control ileum than in control colon. 
In comparison to control, there was a heterogeneity of alterations in intraepithelial and 
lamina propria T lymphocyte subsets (Tll +, T8 +, T4 +) in inflammatory bowel disease. B 
lymphocyteS were not detected within the lamina propria, except when found in and 
adjacent to lymphoid aggregates. Leu 7 + cells were uncommon in the lamina propria of 
control ileum and colon and in diseased tissues. The majority of intraepithelial lympho- 
cytes did not express HLA-DR. Epithelial cells of control colon did not express HLA-DR 
w,hile epithelial cells of control ileal tissues and of diseased colonic and ileal specimens 
expressed HLA-DR antigen. Only small numbers of lamina propria T cells expressed 
HLA-DR in both control and disease tissues. There was intense expression of HLA-DR by 
monocytes and modest expression of HLA-DR by capillary and lymphatic endothelial 
cells, The induction of HLA-DR expression by diseased colonic epithelium and the 
observation that lymphatic endothelium expresses HLA-DR are new observations, and we 
established that Leu 7 + cells are present in very small numbers in both normal and 
diseased intestine and colon. 
The mucosa of the human intestine is rich in mono- 
nuclear cells, the predominant cell types being 
lymphocytes, plasma cells, and macrophages. The 
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cells of the mucosa are found in two separate 
regions, one consisting of lymphocytes (LPL) and 
mononuclear cells (MNC) located within the lamina 
propria and the other consisting largely of lympho- 
cytes located within the epithelial cell layer, intra- 
epithelial lymphocytes (IEL) (1-8). Definition of the 
distribution of lymphocytes in normal gut and in the 
intestine and colon of inflammatory bowel disease 
(IBD) may provide new insights concerning the 
immunopathology of IBD. Cerf-Bensussan et al 
have provided data in this regard in three control 
intestinal specimens (3), while Selby et al have 
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repor ted data in control  colon and in the colon of  
ulcerative colitis (UC) and of  Crohn'S disease (CD) 
(4). Using monoclonal  antibodies to T lymphocytes  
(T11, T8, T4), B lymphocytes (B1), natural killer cells 
(Leu 7), and human leukocyte antigen, DR (HLA-DR) 
antigen (I2), we have further characterized the distri- 
bution of lymphocyte subsets in the intestinal and 
colonic mucosa of controls and of patients with ileal 
and colonic Crohn's disease and of patients with 
ulcerative colitis. Our data confirms and considerably 
extends the earlier observations (3, 4). 
MATERIALS AND METHODS 
Source of Tissue. Specimens of intestinal tissue were 
obtained from surgical procedures performed for diagnos- 
tic and therapeutic purposes at the University of Michi- 
gan aliiliated hospitals. The specimens used for control 
purposes were obtained from grossly and histologically 
normal margins of 10 colonic (all colon cancer) and seven 
ileal specimens (five colon cancer, one chronic pancrea- 
tiffs, one benign ileal stricture) obtained from patients 
without inflammatory bowel disease of the intestine. The 
IBD specimens were obtained from 11 patients with 
ulcerative colitis (nine surgical resections, two endo- 
scopic procedures) and 11 surgical resections of patients 
with Cr0hn's disease, all specimens showing characteris- 
tic features of disease grossly and microscopically. 
Whenever possible, grossly normal-appearing margins 
from the uninvolved area in the IBD specimens were 
obtained for comparison to the grossly affected areas of 
disease (four UC and eleven CD). None of the grossly 
normal margins of IBD specimens were Used to define 
control values. All specimens showed histologic changes 
of active IBD including acute and chronic inflammation, 
crypt epithelial damage, and often mucus depletion. The 
studies described were approved in advance by the 
Human Studies Committee at the respective hospitals. 
The tissue specimens were obtained immediately after 
resection and placed in OCT compound, Tissue Tek II 
(Lab Tek Products, Division of Miles Laboratory, 
Napeville, Illinois) and quick frozen in 2-methyibutane 
(isopentane) (J. T. Baker Chemical Co., Phillipsburg, 
New Jersey) cooled in liquid nitrogen (9). Specimens 
were stored at -70~ until prepared for staining. 
Patient Treatments. Of the 11 patients with ulcerative 
colitis, two were receiving corticosteroids alone, three 
were receiving sulfasalazine (Azulfidine, Pharmacia, Inc.) 
alone, and four were receiving both corticosteroids and 
sulfasalazine at the time the tissue specimens Were ob- 
tained. Of the 11 patients with Crohn's disease, four were 
receiving corticosteroids alone, four were on sulfa- 
salazine, and three were being treated with both agents. 
Clinical activity was determined by patient history, ie, 
presence or absence of abdominal pain, blood per 
rectum, number of stools per day, fever, and arthralgias. 
Chemical parameters evaluated included CBC and 
differential, albumin, and potassium levels. All patients 
except one were clinically active when the specimen was 
collected. 
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Monoelonal Antibodies. Monoclonal antibodies were 
used to stain T lymphocytes and their subsets, B cellS, 
natural killer cells, and cells expressing HLA-DR-like 
surface antigen. The monoclonal antibodies to B cells, 
HLA-DR-like antigen, and T lymphoc~ctes and their sub- 
sets were of the Coulter Clone TM group, (Coulter Immu- 
nology, a division of Coulter Corporation, Hialeah, Flor- 
ida). The monoclonal antibody to natural killer cells was 
obtained from Becton Dickinson Monoclonal Antibody 
Center (Sunnyvale, California). The specificity of the 
individual monoclonal antibodies is as follows: anti-Tll 
identifies t h e  antigen found on greater than 95% of 
thymocytes and 100% of E rosetting-positive lympho- 
cyte s, and inhibits sheep erythrocyte rosette formation. 
Anti-T8 adheres to the lymphocyte surface antigen Which 
identifies suppressor lymphocytes. Anti-T4 identifies T 
lymphocytes which provide a helper role. Anti-Leu 7 
reacts with lymphocytes exhibiting natural killer cell 
activity. Anti-I2 reacts with surface Ia-like (HLA-DR) 
antigen found on normal B cells, monocytes, and acti- 
vated T lymphocytes. B1 antibody reacts with normal B 
cells. The antigen detected by B1 antibody is lost prior to 
the cells' differentiation into a plasma cell. The dilutions 
found to be optimal were as follows: anti-T11 = 1: i280, 
anti-T8 = 1:160, anti-T4 = 1:160, anti-Leu 7 = 1:320, 
anti-B1 = 1:40, anti-I2 = 1:2560 and 1:5120. The above 
concentrations were obtained by diluting the stock solu- 
tion in 2% fetal calf serum (FCS) in phosphate-buffered 
saline (PBS) with 0.002% merthiolate used as preserva- 
tive. These dilutions optimized localization of cells and 
decreased background diffusion of antibody. Monoclonal 
antibody stock solutions were stored at -20~ and di- 
luted aliquots were kept for a maximum of 30 days at 4~ 
The working solutions were stOred at 4~ for rio longer 
than 24 hr and then discarded. All monoclonal antibodies 
were shown to stain peripheral blood mononuclear cells 
Of normal individuals in appropriate proportions. Con- 
trols consisted of staining of sections in the absence of 
primary antibody and staining of sections with amino- 
ethylcarbazole alone (see below). Also, selected tissues 
were stained with mouse IgG and IgM in order to check 
for nonspecific binding of mouse antibody. To look for 
endogenous avidin-binding activity (EABA), a subset of 
tissue sections were incubated with avidin, 1 mg/ml in 
PBS for 20 min, and biotin, 0.1 mg/ml in PBS for 20 min, 
prior to staining (10). No EABA was detected in the four 
control and four disease specimens stained. 
Immunoperoxidase Procedure. Frozen tissue sections 
were cut on a cry0stat microtome (Ames Cryostat II, 
Miles Lab.) and stained according to Warnke and Levy 
(9). Cryostat sections 4 ~m thick were mounted on 
microslides previously coated with 0.5% albumin in 0.1% 
ammonia in water (11). The tissue sections were fixed in 
acetone at room temperature for less than 5 sec and 
stored at -20~ until used. Sections selected for staining 
were fixed in cold acetone for an additional 10 min, then 
incubated with the appropriate dilution of the working 
antibody for 15 min followed by normal horse or goat 
serum (5% serum in 2% FCS in PBS) for 20 rain (9). This 
was followed by incubation with a 1:100 dilution (15 
~g/ml) of biotinylated horse antimouse IgG (Vector 
Labs., Burlingame, California) or biotinylated goat anti- 
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mouse IgM (Vector Labs) in 2% FCS/PBS depending on 
the immunoglobutin class of the primary antibody (9, 12). 
The section was then incubated with avidin-horseradish 
peroxidase (HRP) (Vector Labs) at a final concentration 
of 25 ~g/ml diluted in 2% FCS in PBS at pH 7.2 for 15 min 
(13, 14). Each incubation was followed by two 3-min PBS 
(pH 7.4) washes. After the avidin-HRP incubation the 
sections we, re incubated with a solution of 3-amino-9- 
ethylcarbazole (AEC) (Sigma Chemical Company, St. 
Louis, Missouri) in N,N-dimethylformamide and 0.05 M 
acetate buffer pH, 5.0 with 0.5-3% hydrogen peroxide for 
3-5 min, washed in PBS for 3 min and postfixed in 4% 
formaldehyde for 5 min (3). All sections were coun- 
terstained with Mayer's hematoxylin for 5 rain and 
mounted in Gelvatol (Monsanto, Springfield, Massachu- 
setts) (3). 
Inactivation of Endogenous Peroxidase. There are a 
number of cells in the lamina propria, especially of 
diseased tissues that contain endogenous peroxidase 
(PMN and eosinophilic leukocytes, mast cells, and mac- 
rophages). Considerable effort was made to develop 
methods for inhibiting endogenous peroxidase (EP), but 
most of the approaches that work for standard antibody 
localization were found to inactivate the antigenic sites 
recognized by the monoclonal antibodies utilized. H202 
in methanol, periodic acid-sodium borohydride (15), and 
0.1% phenylhydrazine (16) either failed to adequately 
inhibit EP, or abolished all monoclonal antibody staining. 
Incubation of the sections in varying concentrations of 
sodium azide at various temperatures (17) resulted in 
moderate success in inhibiting EP without affecting 
antigenic sites to monoclonal antibodies. Thus, we 
stained all tissues with the specific monoclonal antibody 
in the presence and absence of sodium azide (Fisher 
Scientific Co., Fairlawn, New Jersey) 0.25 M in 0.25 M 
phosphate buffer, pH 5.0, for 30 min at 37~ The 
treatment with azide was done after the incubation with 
biotinylated secondary antibody. The azide incubation 
was followed by a 20-min wash in PBS. The sections were 
then treated with avidin-horseradish peroxidase and 
AEC. 
All counts were made of slides incubated in both the 
presence and absence of sodium azide. We may have 
overestimated the number of positively stained cells in 
untreated slides, and we may have underestimated the 
number of positively stained cells in the azide-treated 
slides. The data for both groups were analyzed separately 
and not found to be statistically different. The results 
were thus combined. 
Double Staining with Peroxidase and Fluorescein. Tissue 
sections were prepared as previously described and 
stained with anti-human HLA-DR antibody (biotin con- 
jugated) (Becton-Dickinson, Mountain View, California) 
for 15 min, washed in PBS, and incubated with 
avidin-HRP (Vector Labs.) for 15 min. After a PBS wash, 
the avidin-HRP was developed by a 4-min incubation 
with AEC as described. After a 10-rain wash in PBS, the 
tissue was incubated with anti-Tll antigen-fluorescein 
isothiocyanate conjugate (Coulter Clone TM, Coulter Leas- 
ing Corp., Hialeah, Florida) for 30 rain (10, 18). The 
section was then washed and mounted in Gelvatol (3). 
Control sections were stained consecutively with the 
same antibody in order to show that the first conjugated 
antibody blocked subsequent staining with the second 
conjugate of the same antibody. In order to exclude 
inhibition of binding by each of the antibodies, the slides 
were stained by exchanging the fluorescent and avidin 
preparations and then compared (10). Counting was per- 
formed on a Zeiss epifluorescent microscope at a magni- 
fication of 400x, using water-immersion objectives. 
Method of Quantitation. All tissue sections were first 
observed under 100• magnification to assess integrity of 
the tissue section. The section was then scanned at 400• 
and cells stained positively with the mon0clonal antibody 
were counted. The specific reaction of the monoclonal 
antibody with the appropriate surface antigen was defined 
as a circumferential staining of a bright reddish brown 
color with minimal diffusion. The labeled IEL were 
counted per 100 epithelial cells by counting only areas 
where epithelial cells were normally sectioned (2). Counts 
were performed over the entire villous surface (3). A 
minimum of 500 epithelial cells were counted. When 
subsets of cells were exceedingly sparse (Leu 7 +, BI+), 
the number of cells per high-power field (HPF, 400• 
were counted. In the presence of trauma, the IEL were 
not counted. In order to count LPL, the sections were 
then scanned at 400 • and all mononuctear cells (exclud- 
ing swollen capillary endothelia) were counted within an 
area positively defined by a grid (1408A from AO Spen- 
cer), and cells stained with the monoclonal antibody were 
counted within the same grid area. The specific reaction 
of the monoclonal antibody with the appropriate surface 
antigen was defined as circumferential staining of a bright 
reddish brown color with minimal diffusion. This con- 
trasted to endogenous peroxidase found in granulocytes 
and in macrophages which was nonspecific staining con- 
sisting of a dull brown color, was granular, and clearly 
cytoplasmic in location. Mononuctear cells with the char- 
acteristic elongated appearance of fibroblasts were not 
counted. At least 500 mononuclear ceils were counted for 
each monoclonal antibody stained section. In order to 
determine which TI1 + cells were also activated, double- 
stained slides were first observed by light microscopy to 
document presence of I2 antigen, and then the identical 
cell was examined for expression of T11 surface antigen 
by epifluorescence. 
Statistical Analysis. The Student's t test was used for all 
calculations. 
RESULTS 
IEL in Control Specimens. Virtually all I E L  were 
T11 + cells, and ileal tissues contained significantly 
greater numbers of T11+, T8 +, and T4 § I E L  (Figure 
1A-D) than control colonic tissues (Table 1). The 
predominant I E L  subtype was the T8 + lymphocyte ,  
which accounted for >80% of IEL.  The T4+/T8 § 
ratios in colon and ileum were similar. I E L  stained 
with anti-B 1 antibody were rarely detected in colon 
(2/251 HPF) or in ileum (2/172 HPF).  Two Leu 7 
positively stained I E L  were noted in 1/7 ileal spec- 
imens (287 HPF) and two Leu 7 + cells were found in 
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Fig 1. (A) Immunoperoxidase staining in the absence of monoclonal antibody (control). Note endogenous peroxidase 
reaction in granulocytes (arrow). All figures in 1A-D were obtained from serial sections of normal intestinal mucosa and are 
magnified approximately 250x. (B) Staining with monoclonal antibody to Tll  surface antigen showing typical peripheral 
staining of T ceils in both lamina propria and in epithelium. (C) Staining with monoclonal antibody to T4 surface antigen (T 
helper). Few IEL (arrow) were stained with anti-T4 antibody. (D) Staining with monoclonal antibody to T8 surface antigen 
(T suppressor). Note numerous IEL staining with anti-T8 antibody. 
2/10 colonic specimens (611 HPF). The epithelium 
of normal ileal specimens stained diffusely with 
anti-I2, the most intense localization being at the 
apex of epithelial cells. The epithelial cells of con- 
trol colon specimens did not stain with this antibody 
(Figure 2A). IEL did not stain. Mouse IgG and IgM 
did occasionally bind nonspecifically to goblet cell 
mucus and to mucus in the lumen, but there was no 
nonspecific binding over other cellular components, 
including epithelial cells devoid of mucus. On occa- 
sion, the number of T4 § and T8 § cells slightly 
exceeded the number of T l l  + ceils. This probably 
relates to the occasional loss of T11 antigen expres- 
sion by T4 § and T8 § cells (3). 
LPL in Control Specimens. Control ileal speci- 
mens had a significantly greater number of T l l  § 
LPL than control colonic tissues (P < 0.05) (Table 
1), largely due to a greater proportion of T4 § LPL 
(P < 0.005). The T4+/T8 + LPL ratio was similar in 
ileal and colonic specimens. The LPL were located 
diffusely throughout the lamina propria in both ileal 
and colonic control tissues. There was no tendency 
for a T-cell subset to be localized to a specific area 
such as at the base of crypts. T l l  § cells were 
diffusely present or were present in the periphery 
(mantle zone) of lymphoid aggregates. Occasional 
T l l  § lymphocytes were present in germinal cen- 
ters. T8 § lymphocytes were sparsely present in the 
periphery of lymphoid follicles and were not noted 
in germinal centers. T helper lymphocytes were 
present in large numbers in the periphery of follicles 
as well as being present in small numbers within 
germinal centers. Few, if any, Bl-stained lympho- 
cytes were detected among LPL except when adja- 
cent to areas of lymphoid aggregates. Numerous B 
lymphocytes were diffusely present in germinal 
596 Digestive Diseases and Sciences, Vol. 31, No. 6 (June 1986) 
INTESTINAL LYMPHOCYTES IN IBD 
Fig 1. Continued.  
centers of lymphoid aggregates and follicles. Leu 
7-stained LPL were quite sparse (Table 2). Leu 
7+-stained cells were occasionally noted in 
lymphoid aggregates, being located predominantly 
in the center of follicles. Surface membrane staining 
with anti-human HLA-DR antibody (I2) was de- 
tected among lamina propria mononuclear cells, 
dendritic appearing cells, fibroblasts, and vascular 
and lymphatic endothelia (Figure 2A). Mononuclear 
cells with the morphology of macrophages showed 
intense surface staining, even when using minute 
concentrations of antibody. Further, there ap- 
TABLE 1. LYMPHOCYTE DISTRIBUTION IN CONTROL ILEAL AND COLONIC SPECIMENS* 
T l l  T8 T4 T4/T8 
Intraepithelial  lymphocytes  (IEL) 
I leum (7) 13.0 • 8.2 13.1 -+ 6.9 2.0 • 2.1 0.13 - 0.1 
t t 
Colon (10) 5.1 -+- 3.6 4.8 -+ 2.3 0.69 • 1.1 0,20 • 0.4 
Lamina  propria lymphocytes  (LPL) 
I leum (7) 33.6 -4- 5.5 13.0 • 3.5 24.8 +- 3.7 2.0 • 0.6 
t 
Colon (10) 27,7 - 6,3 10.8 -+ 4,1 19.0 - 5.9 1,9 • 0.6 
* IEL are expressed  as number  s tained with T11, T8, and "1"4 monoctonal  ant ibody per  100 epithelial 
ceils, and  L P L  as number  stained per  100 mononuclear  cells. T4/T8 expressed  as the  mean  of  the  
ratios of  individual counts  for each specimen.  N u m b e r s  expressed  as mean  • SD. N u m b e r  of  
pat ients  in paren theses .  
t P  < 0.005. 
SP < 0.05. 
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Fig 2. (A) Epithelium of normal colonic mucosa stained for HLA-DR antigen. There is no epithelial staining. Note intense 
peripheral staining of large mononuclear cells in the lamina propria. There is also modest staining of capillary endothelium 
(arrow). 500 x. (B) Epithelium of diseased colon stained for HLA-DR antigen. Note strong expression of HLA-DR over apex 
of epithelial cells. 500x. 
peared to be considerable diffusion of the antigen, 
especially in the presence of numerous macro- 
phages. Only when the antibody was diluted to 
1:5160 (0.18 Ixg/ml) and occasionally 1:10,320 were 
TABLE 2. DISTRIBUTION OF LPL STAINED WITH 
MONOCLONAL ANTIBODY LEU 7* 
No. Leu7 + 
Tissue Patients positive LPL/HPF? 
Control ileum 7 3 15/287 (5.2) 
Crohn's  disease (ileum) 8 7 35/291 (12.0) 
Normal margin 8 6 62/500 (12.4) 
Control colon 10 7 22/611 (3.6) 
Ulcerative colitis 
Diseased 8 7 49/414 (11.8) 
Normal margin 2 2 8/102 (7.8) 
Crohn's  disease (colon) 
Diseased 3 3 22/85 (25.9) 
Normal margin 2 1 5/47 (10.6) 
*The first column represents the number of patients in whom 
specimens were stained with Leu 7 antibody, and the second 
column lists number of patients who had positively stained 
specimens. 
?Number of Leu 7 + LPL and number of high power fields (HPF) 
counted. Number in parentheses is number of Leu 7 + per 
100 HPF. 
we able to adequately localize the surface staining 
by I2 to macrophages. Double staining with anti- 
T11 monoclonal antibody with fluorescein and anti- 
human HLA-DR antibody with avidin-HRP 
showed that 2.0% of T l l  + LPL expressed 12 sur- 
face antigen (five colonic specimens, 1104 LPL 
counted; four ileal specimens, 570 LPL counted). 
HLA-DR staining was noted throughout lymphoid 
follicles, including germinal centers when present. 
IEL in IBD. Virtually all IEL were T l l  § cells. 
The total number of IEL (Tll  § increased slightly 
but not significantly in ulcerative colitis and in 
Crohn's colitis (Table 3). In contrast, the number of 
T l l  § IEL decreased in diseased ileum (P < 0.05 vs 
control) (Table 4) and T8 + IEL decreased to one 
third of the control value in diseased ileal mucosa (P 
< 0.005). IEL T4+/T8 § ratios were similar in con- 
trol and colonic disease specimens, while there was 
an increased ratio in diseased ileum (P < 0.05) 
(Tables 3 and 4). There was a significant increase in 
T8 § IEL in grossly noninvolved areas of UC colon 
when compared to control colon (P < 0.05), but not 
when compared to UC-involved colon (Table 3). 
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TABLE 3. LYMPHOCYTE DISTRIBUTION IN ULCERATIVE COLITIS AND CROHN'S COLITIS* 
Tl l T8 T4 T4/T8 
Intraepithelial lymphocytes  (IEL) 
Ulcerative colitis 
Diseased (11) 6.4 4-- 4.9 5.0 + 2.8 1.60 - 1.5 0.33 -+ 0.3 
Normal margin (4) 7.5 4- 1.9 6.8 -+ 1.3t 0.80 -+ 0.3 0.12 4- 0.04 
Crohn 's  disease of colon 
Diseased (3) 6.7 4- 1.4 4.7 - 1.0 0.78 -+ 0.7 0.16 - 0.2 
Normal margin (3) 5.5 4- 1.4 5.1 -+ 2.4 0.66 -+ 0.4 0.22 4- 0.3 
Lamina propria lymphocytes  (LPL) 
Ulcerative colitis 
Diseased (11) 24.6 4- 6.5 9.4 4- 3.9 20.5 4- 7.1 2.3 +- 0.7 
Normal margin (4) 25.5 4- 3.2 12.1 -+ 1.5 25.5 +- 1.8; 2.1 4- 1.3 
Crohn 's  colitis 
Diseased (3) 21.0 -+ 5.8 8.1 -+ 1.9 17.9 4- 5.2 2.3 - 0.9 
Normal margin (3) 24.0 -+ 10.4 11.6 -+ 4.3 23.4 4- 9.3 2.2 - 1.1 
*IEL are expressed as number stained with T11, T8, and T4 monocional antibody per  100 epithelial 
cells, and LPL as number stained per 100 mononuclear cells. T4/T8 expressed as the mean of  the 
ratios of individual counts for each specimen. Results expressed as mean 4- sI). Number  of  
patients in parentheses.  
?P < 0.05 when compared to control colon. 
; P  < 0.01. 
B1 + lymphocytes were rarely detected in diseased 
epithelium, 1.5 per 100 high power fields in Crohn's 
ileum (217 HPF counted) and 1 per 100 high power 
fields in UC (291 HPF counted). Less than 1 per 100 
HPF Leu 7 + lymphocytes were observed in speci- 
mens of one of 11 patients with Crohn's disease of 
colon and ileum (400 HPF counted) and one of eight 
patients with ulcerative colitis (414 HPF counted). I2 
staining in IBD was remarkable in that the epithelium 
of all samples of grossly involved colonic mucosa 
obtained from patients with UC and Crohn's colitis 
was positive while normal colonic epithelium did not 
express I2 (Figure 2A, B). Two of 10 patients with 
Crohn's ilei[tis and colitis had one and two IEL stained 
with anti-I2, respectively, in 271 HPF counted. None 
of the UC ]patients had I2 + IEL in 229 HPF. 
LPL in IBD. T cells in ulcerative colitis were not 
significantly different from control specimens, ex- 
cept that the number of T4 § LPL were significantly 
increased in grossly noninvolved margins in ulcer- 
ative colitis (P < 0.01) (Table 3). T4+/T8 + ratios 
were similar in diseased and control tissues. T 
lymphocyte subsets in Crohn's ileitis specimens 
were similar to the control ileal samples except for 
a significant decrease in number of T l l  § lympho- 
cytes per 100 mononuclear cells in involved (P < 
0.05) and noninvolved areas (P < 0.005) when 
compared to control (Table 4). There were no 
significant changes in T4+/T8 + ratios. No apparent 
differences could be detected in the T lymphocyte 
subset distribution in lymphoid aggregates found in 
ulcerative colitis and Crohn's colitis specimens 
when compared to control. Four of eight patients 
with Crohn's ileitis had a total of 18 B1 + lympho- 
cytes in 217 HPF counted and four of 11 patients 
with ulcerative colitis had a total of 11 B 1 § lympho- 
TABLE 4. LYMPHOCYTE POPULATIONS IN CROHN'S DISEASE OF ILEUM 
"#11 T8 T4 T4/T8 
Intraepithelial lymphocytes  (IEL) 
Diseased (8) 6.6 4- 4.4t  4.31 -+ 2.3t 1.1 4- 0.7 0.37 + 0.5t  
Normal margin (8) 7.1 -+ 3.2t 8.0 4- 6.1t 1.5 4- 1.0 0.22 -+ 1.07 
Lamina propria lymphocytes  (LPL) 
Diseased (8) 27.5 + 7.0;  i l .3  4- 4.6 21.5 4- 5.0 2.2 4- 0.9 
Normal margin (8) 25.0 -+ 7.4t  13.6 --- 4.9 24.3 -+ 5.7 2.0 -+ 0.7 
*IEL are expressed as number stained with T11, T8, and T4 monoclonal antibody per 100 epithelial 
cells, and LPL as number stained per  100 mononuclear cells. T4/T8 expressed as the mean of  the 
ratios of individual counts for each specimen. Results expressed as mean -+ SD. Number  of  
patients in parentheses.  
?P < 0.005 when compared to control. 
SP < 0.05. 
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Fig 3. (A) Mucosa in Crohn's ileitis specimen stained for HLA-DR antigen demonstrating staining of epithelium, 
large mononuclear cells in the lamina propria, and of the endothelium of a lacteal (arrow). 500• (B) Submucosa in 
Crohn's ileitis specimen stained for HLA-DR antigen demonstrating strong staining of capillary endothelium. 500 • 
cytes in 291 HPF counted. Two patients with 
Crohn's ileitis had lymphoid aggregates with B cells 
located predominantly in germinal centers; four 
patients with ulcerative colitis had numerous B cells 
in the center of lymphoid aggregates. Seven of eight 
patients with Crohn's ileitis, seven of eight patients 
with ulcerative colitis, and all three patients with 
Crohn's colitis had presence of small numbers of 
Leu 7 + ceils (Table 2). Leu 7 § lymphocytes were 
detected in small numbers within lymphoid aggre- 
gates in ulcerative colitis specimens but were not 
present within lymphoid aggregate s of the three 
Crohn's ileitis specimens. I2 antibody stained mac- 
rophages, vascular and lymphatic endothelia (Fig- 
ure 3A, B), and fibroblasts. Diffusion of antigen 
around macrophages was again prominent at lower 
concentrations of antibody. Double staining with 
T l l  antibody and I2 antibody detected 0.8% --- 1.3 
I2+/Tll § LPL in ulcerative colitis (seven speci- 
mens, 1026 counts) and 1.3% --- 1.1 I2§ + LPL 
in Crohn's ileitis tissues (five specimens, 1269 
counts). All specimens containing lymphoid folli- 
cles showed diffuse anti-HLA-DR staining within 
the follicle, ie, most cells appeared to be stained. 
We did not compare data in steroid-treated pa- 
tients versus non-steroid-treated patients because 
the sample size of non-steroid-treated patients was 
not large enough to permit valid conclusions. 
DISCUSSION 
We have characterized IEL and LPL distribution 
in control colon and ileum and in ulcerative colitis 
and in Crohn's disease, using monoclonal antibod- 
ies to T and B lymphocytes, natural killer cells, and 
to HLA-DR antigen. We report analysis of lympho- 
cyte distribution in ileal Crohn's disease for the first 
time and provide extensive quantitative data con- 
cerning lymphocyte distribution in colonic Crohn's 
disease and in ulcerative colitis. IEL are T lympho- 
cytes with the predominant subset being the T 
suppressor (T8 § type in both ileal and in colonic 
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mucosa. .Control  ileal tissues had significantly 
greater numbers of T l l  +, T8 +, and T4 + IEL than 
did control colonic tissues while the T4 to T8 ratios 
were similar in both tissues. Our data in control ileal 
specimens is similar to that of Cerf-Bensussan et al, 
who reported 12 ___ 5.0 T lymphocytes/100 epithelial 
cells, and 11 -+ 6.0 T suppressor (T8 § lympho- 
cytes/100 epithelial cells in "three specimens of 
normal small intestine" (3). However, Cerf-Bensus- 
san et al found three times as many T helper (T4 +) 
IEL/100 epithelial cells than we found (3). This 
difference may be due to the differences in tech- 
nique, differences in specificity of the anti-T4 mono- 
clonal antibody used, or to differences in tissue 
(ileum vs probable jejunum). We show quantita- 
tively that the predominance of T suppressor (T8 § 
IEL lymphocytes is maintained in UC and CD (4), 
and demonstrate this in both grossly involved and 
grossly noninvolved areas of the ileum and colon. 
There was a significant increase of T8 + IEL in 
grossly normal margins of UC specimens. There 
was a significant decrease in the number of IEL in 
diseased tissues in ileal CD. 
IEL are clearly a heterogenous population of 
cells with heterogenous functions. We have focused 
on epithelial lymphocytes in this study, but other 
cells, including PMN leukocytes, eosinophils, mast 
cells, and macrophages, may be found within the 
epithelium (2, 8). IEL are increased in numbers in 
several disease states including celiac sprue, tropi- 
cal sprue, and dermatitis herpetiformis (6-8). In 
celiac sprue, the T4 to T8 ratio of IEL is unchanged 
when compared to normal, but the proportion of 
T8 § IEL expressing the pan T cell marker, Leu 1, is 
significantly increased when compared to IEL of 
normal intestine (56% vs 32%) (6). IEL in celiac 
sprue may reflect increased traffic into the epithe- 
lium, although the function of human IEL is not 
known (6). The epithelium is ideally suited to the 
function of suppressor (T8 § cells because of its 
strong expression of class I MHC antigens. The 
small population of helpe r (T4 § cells within the 
epithelium may add further control over the func- 
tions of T8 + IEL (6). 
We have shown some changes in IEL numbers 
and distribution in IBD, but these are rather minor 
in numerical terms, and there is no change in T4 to 
T8 ratio or increase in number of IEL in colonic 
IBD. IEL do show an increase in the T4 to T8 ratio 
and are decreased in number in ileal CD. Thus there 
is no increase (and even a decrease in Crohn's 
ileitis) in traffic of IEL in IBD. Epithelial expression 
of HLA-DR antigen may well play a role in antigen 
presentation to IEL (see later discussion), although 
this is speculative at best. The role of PMN leuko- 
cytes in injury to epithelial cells, particularly in UC, 
is a topic beyond the scope of this study. 
Finally, it should be noted that human IEL, in 
contrast to rodent IEL, do not contain large gran- 
ules (1-3, 8). Occasional small granules are present 
within human IEL, but these are probably lyso- 
somes (1-3). Rodent IEL may be mast cell derived, 
while there is no evidence that human IEL are mast 
cell in origin (19). 
There are two methods of quantitation of IEL. 
One is to count the number of IEL per unit area of 
mucosa and the other is to count the number of IEL 
per 100 epithelial cells (20). For example, in celiac 
sprue there is an increase in numbers of IEL/100 
epithelial cells while there is a decrease in numbers 
of IEL per unit area (millimeters of muscularis 
mucosae) of gut (20). The epithelial region is morpho- 
logically and functionally different from the lamina 
propria region (1, 3, 5-7, 20). We suggest that the IEL 
immune role is directed towards the epithelial cell 
(1, 2). Thus, we chose to quantitate the number of 
IEL/t00 epithelial cells. We emphasize, however, 
that the method of quantitation of IEL must be 
considered to be arbitrary and the "correct"  
method of quantitation has not been established. 
We confirm that few B lymphocytes were tbund 
in the IEL population (3, 4, 7) and those few cells 
could have represented artifactual staining. The 
paucity of natural killer cells (Leu 7 ~) among IEL in 
control tissues as well as in diseased areas confirms 
earlier studies (3, 6). 
The expression of HLA-DR antigen on macro- 
phages and lymphocytes is one indication of im- 
mune activation (21). Our data indicate that the IEL 
is not an activated cell (4-6), at least on the basis of 
I2 expression. Normal intestinal epithelium and 
ileal CD epithelium express I2, while control co- 
Ionic epithelium did not. The epithelium of all 
colonic IBD specimens expressed I2. The induction 
of epithelial cell expression of HLA-DR-like anti- 
gen in UC has been used to suggest an autoimmune 
mechanism for colonic IBD (22), but there is no 
direct data bearing on this supposition. However, it 
has been shown that both induction of graft-vs-host 
disease and naturally occurring immunological 
stimuli can also induce the expression of Ia antigens 
(HLA-DR-like) in rat intestinal epithelium (23). 
In regard to LPL, there were more T tympho- 
cytes (Tll  +) per 100 mononuclear cells in control 
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ileum than in control colon, while the T4+/T8 § 
ratios were similar in both tissues. The ratio of 
T4+/T8 § LPL in grossly diseased tissues in ulcer- 
ative colitis and in Crohn's colitis and ileitis was 
similar to that of controls. Interestingly, there was a 
significant increase in the proportion of T helper 
cells in normal margins of ulcerative colitis speci- 
mens. However, there was a sufficient increase in T 
suppressor cells so that the T4/T8 ratio was not 
significantly changedl Our data show that there is a 
generalized inflammatory response in IBD which 
includes T cells and that there is no change in ratio 
of helper (T4 § cells to suppressor (T8 § cells. In 
Crohn's ileitis there was a decrease in the propor- 
tion of T l l  § cells/100 MNC but no change in the 
ratio of T4+/T8 + cells. This decrease in the propor- 
tion of T 11 + cells may be secondary to an increased 
infiltration by other MNC such as plasma cells and 
macrophages. Plasma cells were included in our 
counts of MNC but were not counted separately. 
An increase in lamina propria plasma ceils in IBD is 
well documented (24). 
Lymphocytes staining with anti-B1 monoclonal 
antibody were so rare among diffuse lymphoid 
tissues in control and disease specimens as to be 
regarded as artifactual. B cells were prominent, as 
expected, within germinal centers of lymphoid ag- 
gregates. Plasma ceils lose the antigenic marker 
defined by anti-B 1 when they differentiate from B 
cells, and presumably B cells that home to  the 
mucosa lose the B lma rke r  prior to localization in 
the lamina propria. We did note an increase in B 
cells in Crohn's colitis, but these were generally 
located adjacent to lymphoid aggregates, where 
B1 § cells are normally present. 
Natural killer (Leu 7 § lymphocytes were rarely 
detected in control ileal specimens. This supports 
other immunohistological and in vitro data indicat- 
ing that there are few natural killer cells among LPL 
(4, 6, 25). We did find more Leu 7 § cells/HPF in 
specimens from patients with Crohn's ileitis, 
Crohn's colitis, and in ulcerative colitis. This find- 
ing may be part of a generalized inflammatory 
response and does not necessarily indicate a pri- 
mary role for N K  cells in IBD. Recently, Leu l l a  
monoclonal antibody has been shown to label all 
cells with natural killer (NK) activity, while Leu 7 
labels only 80% of NK activity. We have utilized 
fluorosceinated Leu l la  (data not shown) in se- 
lected tissues (those showing occasional Leu 7 + 
cells) and confirm that there are comparable num- 
bers of labeled cells using both techniques. Targan 
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et al (26) have shown, in contrast to earlier con- 
flicting reports, that natural killer cell activity is 
present in the colonic mucosa and that it constitutes 
only about 1.5% of isolated IEL and LPL com- 
bined. Our data are consistent with the findings of 
Targan et al of a paucity of natural killer cells in the 
colonic mucosa. 
Few lamina propria T cells expressed 12, either in 
control or in IBD specimens. Similar findings were 
reported in control ileum by Cerf-Bensussan et al 
and in IBD by Selby et al (3, 4). I2 (HLA-DR) 
expression by macrophages, by capillary and lym- 
phatic endothelia, and by cells similar morphologi- 
cally to fibroblasts was present. The expression by 
macrophages was intense. I2 expression by mono- 
cytes and macrophages, capillary endothelia, intes- 
tinal epithelium, and fibroblasts is documented (21, 
22, 27-29). We describe I2 localization to lymphatic 
endothelia in the intestine for the first time. HLA- 
DR-like (class II MHC antigen) expression is re- 
quired in the initiation of the T-helper response to 
many antigens, including bacterial antigens (22). 
The strong expression of HLA-DR may PlaY a role 
in the immune response (hyperresponse?) of IBD. 
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